Singapore, Singapore

Navin Kumar Verma

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Navin Kumar Verma

Introduction

Navin Kumar Verma is a notable inventor based in Singapore, recognized for his contributions to the field of antimicrobial peptides. His innovative work focuses on modifying peptides to enhance their therapeutic properties while reducing cytotoxicity. With a single patent to his name, Verma's research has significant implications for pharmaceutical applications.

Latest Patents

Navin Kumar Verma holds a patent titled "Antimicrobial peptides comprising epsilon lysine residues." This patent describes a peptide that includes at least five amino acid residues, with modifications that enhance its antimicrobial activity. The modified peptides are designed to display reduced or no cytotoxicity compared to their non-modified counterparts. The patent also covers pharmaceutical compositions and methods for using these peptides in treating various conditions, including microbial infections and inflammation.

Career Highlights

Throughout his career, Verma has worked with prominent organizations such as Singapore Health Services Pte Ltd and Nanyang Technological University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in peptide research.

Collaborations

Some of his notable coworkers include Lakshminarayanan Rajamani and Venkatesh Mayandi. Their collaborative efforts have furthered the understanding and application of antimicrobial peptides in medical science.

Conclusion

Navin Kumar Verma's innovative work in the field of antimicrobial peptides showcases his commitment to advancing medical research. His contributions have the potential to improve therapeutic outcomes and enhance patient safety.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…